Sodium thiopental
| Clinical data | |
|---|---|
| Trade names | Pentothal, others |
| Other names | Truth serum, thiopentone, thiopental |
| AHFS/Drugs.com | Monograph |
| Pregnancy category |
|
| Routes of administration | Intravenous, by mouth, rectal |
| Drug class | Barbiturate |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | 80% |
| Metabolism | Liver |
| Metabolites | Pentobarbital, others |
| Onset of action | 30–45 seconds |
| Elimination half-life | 5.5–26 hours |
| Duration of action | 5–10 minutes |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.694 |
| Chemical and physical data | |
| Formula | C11H17N2NaO2S |
| Molar mass | 264.32 g·mol−1 |
| 3D model (JSmol) | |
| Chirality | Racemic mixture |
| |
| |
Sodium thiopental, also known as thiopental sodium or thiopentone and sold under the brand name Pentothal, is a rapid-onset short-acting barbiturate general anesthetic. It is the thiobarbiturate analog of pentobarbital, and an analog of thiobarbital. Sodium thiopental is a therapeutic alternative on the World Health Organization's List of Essential Medicines. It was the first of three drugs administered during most lethal injections in the United States until the US division of Hospira objected and stopped manufacturing the drug for this purpose in 2011, and the European Union additionally banned the export of the drug for this purpose. Although thiopental abuse carries a dependency risk, its recreational use is rare.
Sodium thiopental is well-known in popular culture, especially under the name "sodium pentothal," as a "truth serum," although its efficacy in this role is questioned.